{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T18:38:08Z","timestamp":1772131088015,"version":"3.50.1"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Funct Integr Genomics"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s10142-024-01283-5","type":"journal-article","created":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T01:14:44Z","timestamp":1710292484000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identification of RNA methylation-related lncRNAs for prognostic assessment and immunotherapy in bladder cancer\u2014based on single cell\/Bulk RNA sequencing data"],"prefix":"10.1007","volume":"24","author":[{"given":"LianMing","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zili","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangdie","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baoluo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,13]]},"reference":[{"issue":"7","key":"1283_CR1","doi-asserted-by":"publisher","first-page":"e3338","DOI":"10.1002\/jgm.3338","volume":"23","author":"M Bai","year":"2021","unstructured":"Bai M, Wu ZZ, Huang YL, Ke J, Xu Q, Wang X (2021) STAT3 activates the transcription of lncRNA NR2F1-AS1 to promote the progression of melanoma via regulating the miR-493-5p\/GOLM1 axis. J Gene Med 23(7):e3338. https:\/\/doi.org\/10.1002\/jgm.3338. (From NLM)","journal-title":"J Gene Med"},{"issue":"8","key":"1283_CR2","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/s41556-019-0361-y","volume":"21","author":"X Chen","year":"2019","unstructured":"Chen X, Li A, Sun BF, Yang Y, Han YN, Yuan X, Chen RX, Wei WS, Liu Y, Gao CC et al (2019) 5-Methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol 21(8):978\u2013990. https:\/\/doi.org\/10.1038\/s41556-019-0361-y. (From NLM)","journal-title":"Nat Cell Biol"},{"issue":"1","key":"1283_CR3","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","volume":"150","author":"MA Dawson","year":"2012","unstructured":"Dawson MA, Kouzarides T (2012) Cancer epigenetics: from mechanism to therapy. Cell 150(1):12\u201327. https:\/\/doi.org\/10.1016\/j.cell.2012.06.013. (From NLM)","journal-title":"Cell"},{"key":"1283_CR4","doi-asserted-by":"publisher","unstructured":"Dobruch J, Oszczud\u0142owski M (2021) Bladder cancer: current challenges and future directions. Medicina (Kaunas, Lithuania) 57(8). https:\/\/doi.org\/10.3390\/medicina57080749. From NLM","DOI":"10.3390\/medicina57080749"},{"key":"1283_CR5","doi-asserted-by":"publisher","unstructured":"Gu L, Guo H, Wu LX, Yuan JB (2023) Prognostic analysis and validation of lncRNAs in bladder cancer on the basis of neutrophil extracellular traps. J Gene Med e3525. https:\/\/doi.org\/10.1002\/jgm.3525. From NLM","DOI":"10.1002\/jgm.3525"},{"issue":"1","key":"1283_CR6","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s12943-019-1036-9","volume":"18","author":"J Han","year":"2019","unstructured":"Han J, Wang JZ, Yang X, Yu H, Zhou R, Lu HC, Yuan WB, Lu JC, Zhou ZJ, Lu Q et al (2019) METTL3 promote tumor proliferation of bladder cancer by accelerating pri-miR221\/222 maturation in m6A-dependent manner. Mol Cancer 18(1):110. https:\/\/doi.org\/10.1186\/s12943-019-1036-9. (From NLM)","journal-title":"Mol Cancer"},{"issue":"5","key":"1283_CR7","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41419-021-03715-7","volume":"12","author":"C Han","year":"2021","unstructured":"Han C, Li H, Ma Z, Dong G, Wang Q, Wang S, Fang P, Li X, Chen H, Liu T et al (2021) MIR99AHG is a noncoding tumor suppressor gene in lung adenocarcinoma. Cell Death Dis 12(5):424. https:\/\/doi.org\/10.1038\/s41419-021-03715-7. (From NLM)","journal-title":"Cell Death Dis"},{"issue":"9","key":"1283_CR8","doi-asserted-by":"publisher","first-page":"e19805","DOI":"10.1016\/j.heliyon.2023.e19805","volume":"9","author":"W Han","year":"2023","unstructured":"Han W, Shi CT, Chen H, Zhou Q, Ding W, Chen F, Liang ZW, Teng YJ, Shao QX, Dong XQ (2023) Role of LncRNA MIR99AHG in breast cancer: bioinformatic analysis and preliminary verification. Heliyon 9(9):e19805. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e19805. (From NLM)","journal-title":"Heliyon"},{"key":"1283_CR9","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-0716-1266-8_3","volume":"2276","author":"S Hartwig","year":"2021","unstructured":"Hartwig S, Kotzka J, Lehr S (2021) Isolation and quality control of functional mitochondria. Methods Mol Biol 2276:41\u201355. https:\/\/doi.org\/10.1007\/978-1-0716-1266-8_3. (From NLM)","journal-title":"Methods Mol Biol"},{"issue":"12","key":"1283_CR10","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"AB Herman","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M (2022) Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell 82(12):2252\u20132266. https:\/\/doi.org\/10.1016\/j.molcel.2022.05.027. (From NLM)","journal-title":"Mol Cell"},{"issue":"6","key":"1283_CR11","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1038\/s41418-019-0461-z","volume":"27","author":"X Hu","year":"2020","unstructured":"Hu X, Peng WX, Zhou H, Jiang J, Zhou X, Huang D, Mo YY, Yang L (2020) IGF2BP2 regulates DANCR by serving as an N6-methyladenosine reader. Cell Death Differ 27(6):1782\u20131794. https:\/\/doi.org\/10.1038\/s41418-019-0461-z. (From NLM)","journal-title":"Cell Death Differ"},{"issue":"9","key":"1283_CR12","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1038\/s41419-021-04127-3","volume":"12","author":"Y Hu","year":"2021","unstructured":"Hu Y, Chen C, Tong X, Chen S, Hu X, Pan B, Sun X, Chen Z, Shi X, Hu Y et al (2021) NSUN2 modified by SUMO-2\/3 promotes gastric cancer progression and regulates mRNA m5C methylation. Cell Death Dis 12(9):842. https:\/\/doi.org\/10.1038\/s41419-021-04127-3. (From NLM)","journal-title":"Cell Death Dis"},{"issue":"1","key":"1283_CR13","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1038\/s41598-023-30865-9","volume":"13","author":"Y Huang","year":"2023","unstructured":"Huang Y, Zhang W, Li Q, Wang Z, Yang X (2023) Identification of m6A\/m5C\/m1A-associated LncRNAs for prognostic assessment and immunotherapy in pancreatic cancer. Sci Rep 13(1):3661. https:\/\/doi.org\/10.1038\/s41598-023-30865-9. (From NLM)","journal-title":"Sci Rep"},{"issue":"6","key":"1283_CR14","doi-asserted-by":"publisher","first-page":"9105","DOI":"10.1002\/jcp.27587","volume":"234","author":"X Kong","year":"2019","unstructured":"Kong X, Duan Y, Sang Y, Li Y, Zhang H, Liang Y, Liu Y, Zhang N, Yang Q (2019) LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol 234(6):9105\u20139117. https:\/\/doi.org\/10.1002\/jcp.27587. (From NLM)","journal-title":"J Cell Physiol"},{"issue":"1","key":"1283_CR15","doi-asserted-by":"publisher","first-page":"3703","DOI":"10.1038\/s41467-022-31535-6","volume":"13","author":"J Kong","year":"2022","unstructured":"Kong J, Ha D, Lee J, Kim I, Park M, Im SH, Shin K, Kim S (2022) Network-based machine learning approach to predict immunotherapy response in cancer patients. Nat Commun 13(1):3703. https:\/\/doi.org\/10.1038\/s41467-022-31535-6. (From NLM)","journal-title":"Nat Commun"},{"issue":"1","key":"1283_CR16","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.eururo.2023.04.020","volume":"84","author":"S Koutros","year":"2023","unstructured":"Koutros S, Kiemeney LA, Pal Choudhury P, Milne RL, Lopez de Maturana E, Ye Y, Joseph V, Florez-Vargas O, Dyrskj\u00f8t L, Figueroa J (2023) Genome-wide association study of bladder cancer reveals new biological and translational insights. European Urol 84(1):127\u2013137. https:\/\/doi.org\/10.1016\/j.eururo.2023.04.020. (From NLM)","journal-title":"European Urol"},{"issue":"11","key":"1283_CR17","doi-asserted-by":"publisher","first-page":"e2244430","DOI":"10.1001\/jamanetworkopen.2022.44430","volume":"5","author":"ML Kwan","year":"2022","unstructured":"Kwan ML, Haque R, Young-Wolff KC, Lee VS, Roh JM, Ergas IJ, Wang Z, Cannavale KL, Ambrosone CB, Loo RK et al (2022) Smoking behaviors and prognosis in patients with non-muscle-invasive bladder cancer in the be-well study. JAMA Netw Open 5(11):e2244430. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.44430. (From NLM)","journal-title":"JAMA Netw Open"},{"issue":"19","key":"1283_CR18","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD (2020) Bladder cancer: a review. JAMA 324(19):1980\u20131991. https:\/\/doi.org\/10.1001\/jama.2020.17598. (From NLM)","journal-title":"JAMA"},{"key":"1283_CR19","doi-asserted-by":"publisher","first-page":"918140","DOI":"10.3389\/fimmu.2022.918140","volume":"13","author":"D Li","year":"2022","unstructured":"Li D, Li K, Zhang W, Yang KW, Mu DA, Jiang GJ, Shi RS, Ke D (2022a) The m6A\/m5C\/m1A regulated gene signature predicts the prognosis and correlates with the immune status of hepatocellular carcinoma. Front Immunol 13:918140. https:\/\/doi.org\/10.3389\/fimmu.2022.918140. (From NLM)","journal-title":"Front Immunol"},{"issue":"1","key":"1283_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12864-022-08350-w","volume":"23","author":"W Li","year":"2022","unstructured":"Li W, Li X, Ma X, Xiao W, Zhang J (2022b) Mapping the m1A, m5C, m6A and m7G methylation atlas in zebrafish brain under hypoxic conditions by MeRIP-seq. BMC Genomics 23(1):105. https:\/\/doi.org\/10.1186\/s12864-022-08350-w. (From NLM)","journal-title":"BMC Genomics"},{"issue":"3","key":"1283_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ (2019) Delivery technologies for cancer immunotherapy. Nat Rev Drug Discovery 18(3):175\u2013196. https:\/\/doi.org\/10.1038\/s41573-018-0006-z. (From NLM)","journal-title":"Nat Rev Drug Discovery"},{"issue":"1","key":"1283_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/sim.7901","volume":"38","author":"WF Rosenberger","year":"2019","unstructured":"Rosenberger WF, Uschner D, Wang Y (2019) Randomization: the forgotten component of the randomized clinical trial. Stat Med 38(1):1\u201312. https:\/\/doi.org\/10.1002\/sim.7901. (From NLM)","journal-title":"Stat Med"},{"key":"1283_CR23","doi-asserted-by":"publisher","first-page":"903117","DOI":"10.3389\/fgene.2022.903117","volume":"13","author":"D Shao","year":"2022","unstructured":"Shao D, Li Y, Wu J, Zhang B, Xie S, Zheng X, Jiang Z (2022) An m6A\/m5C\/m1A\/m7G-Related long non-coding RNA signature to predict prognosis and immune features of glioma. Front Genet 13:903117. https:\/\/doi.org\/10.3389\/fgene.2022.903117. (From NLM)","journal-title":"Front Genet"},{"issue":"19","key":"1283_CR24","doi-asserted-by":"publisher","first-page":"5247","DOI":"10.1158\/1078-0432.Ccr-12-0955","volume":"18","author":"K Shimada","year":"2012","unstructured":"Shimada K, Fujii T, Tsujikawa K, Anai S, Fujimoto K, Konishi N (2012) ALKBH3 contributes to survival and angiogenesis of human urothelial carcinoma cells through NADPH oxidase and tweak\/Fn14\/VEGF signals. Clin Cancer Res 18(19):5247\u20135255. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-0955. (From NLM)","journal-title":"Clin Cancer Res"},{"key":"1283_CR25","doi-asserted-by":"publisher","unstructured":"Sulewska A, Niklinski J, Charkiewicz R, Karabowicz P, Biecek P, Baniecki H, Kowalczuk O, Kozlowski M, Modzelewska P, Majewski P et al (2022) A signature of 14 Long non-coding RNAs (lncRNAs) as a step towards precision diagnosis for NSCLC. Cancers (Basel) 14(2). https:\/\/doi.org\/10.3390\/cancers14020439. From NLM","DOI":"10.3390\/cancers14020439"},{"issue":"2","key":"1283_CR26","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"YT Tan","year":"2021","unstructured":"Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ (2021) LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun (london, England) 41(2):109\u2013120. https:\/\/doi.org\/10.1002\/cac2.12108. (From NLM)","journal-title":"Cancer Commun (london, England)"},{"issue":"8","key":"1283_CR27","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1615\/CritRevEukaryotGeneExpr.2022042848","volume":"32","author":"Y Tan","year":"2022","unstructured":"Tan Y, Liu L, Zhang X, Xue Y, Gao J, Zhao J, Chi N, Zhu Y (2022) THUMPD3-AS1 Is correlated with gastric cancer and regulates cell function through miR-1252-3p and CXCL17. Crit Rev Eukaryot Gene Expr 32(8):69\u201380. https:\/\/doi.org\/10.1615\/CritRevEukaryotGeneExpr.2022042848. (From NLM)","journal-title":"Crit Rev Eukaryot Gene Expr"},{"issue":"1","key":"1283_CR28","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12967-023-04056-z","volume":"21","author":"Z Tan","year":"2023","unstructured":"Tan Z, Chen X, Zuo J, Fu S, Wang H, Wang J (2023) Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model. J Transl Med 21(1):223. https:\/\/doi.org\/10.1186\/s12967-023-04056-z. (From NLM)","journal-title":"J Transl Med"},{"issue":"6","key":"1283_CR29","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/tox.23489","volume":"37","author":"X Wang","year":"2022","unstructured":"Wang X, Zhou Y, Dong K, Zhang H, Gong J, Wang S (2022) Exosomal lncRNA HMMR-AS1 mediates macrophage polarization through miR-147a\/ARID3A axis under hypoxia and affects the progression of hepatocellular carcinoma. Environ Toxicol 37(6):1357\u20131372. https:\/\/doi.org\/10.1002\/tox.23489. (From NLM)","journal-title":"Environ Toxicol"},{"issue":"1","key":"1283_CR30","doi-asserted-by":"publisher","first-page":"2190618","DOI":"10.1080\/07853890.2023.2190618","volume":"55","author":"Y Wang","year":"2023","unstructured":"Wang Y, Mao Y, Wang C, Jiang X, Tang Q, Wang L, Zhu J, Zhao M (2023a) RNA methylation-related genes of m6A, m5C, and m1A predict prognosis and immunotherapy response in cervical cancer. Ann Med 55(1):2190618. https:\/\/doi.org\/10.1080\/07853890.2023.2190618. (From NLM)","journal-title":"Ann Med"},{"issue":"2","key":"1283_CR31","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/s41419-023-05661-y","volume":"14","author":"N Wang","year":"2023","unstructured":"Wang N, Chen RX, Deng MH, Wei WS, Zhou ZH, Ning K, Li YH, Li XD, Ye YL, Wen JH et al (2023b) m(5)C-dependent cross-regulation between nuclear reader ALYREF and writer NSUN2 promotes urothelial bladder cancer malignancy through facilitating RABL6\/TK1 mRNAs splicing and stabilization. Cell Death Dis 14(2):139. https:\/\/doi.org\/10.1038\/s41419-023-05661-y. (From NLM)","journal-title":"Cell Death Dis"},{"key":"1283_CR32","doi-asserted-by":"publisher","first-page":"105937","DOI":"10.1016\/j.phrs.2021.105937","volume":"174","author":"B Yang","year":"2021","unstructured":"Yang B, Wang JQ, Tan Y, Yuan R, Chen ZS, Zou C (2021) RNA methylation and cancer treatment. Pharmacol Res 174:105937. https:\/\/doi.org\/10.1016\/j.phrs.2021.105937. (From NLM)","journal-title":"Pharmacol Res"},{"key":"1283_CR33","doi-asserted-by":"publisher","first-page":"722642","DOI":"10.3389\/fimmu.2021.722642","volume":"12","author":"F Ye","year":"2021","unstructured":"Ye F, Hu Y, Gao J, Liang Y, Liu Y, Ou Y, Cheng Z, Jiang H (2021) Radiogenomics map reveals the landscape of m6A methylation modification pattern in bladder cancer. Front Immunol 12:722642. https:\/\/doi.org\/10.3389\/fimmu.2021.722642. (From NLM)","journal-title":"Front Immunol"},{"issue":"1","key":"1283_CR34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s13045-020-00951-w","volume":"13","author":"C Zeng","year":"2020","unstructured":"Zeng C, Huang W, Li Y, Weng H (2020) Roles of METTL3 in cancer: mechanisms and therapeutic targeting. J Hematol Oncol 13(1):117. https:\/\/doi.org\/10.1186\/s13045-020-00951-w. (From NLM)","journal-title":"J Hematol Oncol"},{"issue":"8","key":"1283_CR35","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/s41423-020-0488-6","volume":"17","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang Z (2020) The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol 17(8):807\u2013821. https:\/\/doi.org\/10.1038\/s41423-020-0488-6. (From NLM)","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"1283_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s13046-020-01687-8","volume":"39","author":"H Zhang","year":"2020","unstructured":"Zhang H, Zhu C, He Z, Chen S, Li L, Sun C (2020) LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p\/STAT1\/PD-L1 axis. J Exp Clin Cancer Res 39(1):179. https:\/\/doi.org\/10.1186\/s13046-020-01687-8. (From NLM)","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1283_CR37","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s13073-022-01050-w","volume":"14","author":"Z Zhang","year":"2022","unstructured":"Zhang Z, Wang ZX, Chen YX, Wu HX, Yin L, Zhao Q, Luo HY, Zeng ZL, Qiu MZ, Xu RH (2022) Integrated analysis of single-cell and bulk RNA sequencing data reveals a pan-cancer stemness signature predicting immunotherapy response. Genome Med 14(1):45. https:\/\/doi.org\/10.1186\/s13073-022-01050-w. (From NLM)","journal-title":"Genome Med"},{"issue":"9","key":"1283_CR38","doi-asserted-by":"publisher","first-page":"107673","DOI":"10.1016\/j.isci.2023.107673","volume":"26","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Li Y, Fan L, Wang B, Liu W, Cui J, Tan B (2023) LncRNA THUMPD3-AS1 promotes invasion and EMT in gastric cancer by regulating the miR-1297\/BCAT1 pathway. iScience 26(9):107673. https:\/\/doi.org\/10.1016\/j.isci.2023.107673. (From NLM)","journal-title":"iScience"},{"issue":"5","key":"1283_CR39","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.4149\/neo_2022_220111N42","volume":"69","author":"F Zhao","year":"2022","unstructured":"Zhao F, Wang M, Zhang Y, Su R, He C, Gao X, Zan Y, Zhang S, Ma Y (2022) lncRNA PSMB8-AS1 promotes colorectal cancer progression through sponging miR-1299 to upregulate ADAMTS5. Neoplasma 69(5):1138\u20131153. https:\/\/doi.org\/10.4149\/neo_2022_220111N42. (From NLM)","journal-title":"Neoplasma"}],"container-title":["Functional & Integrative Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-024-01283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10142-024-01283-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10142-024-01283-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T10:22:39Z","timestamp":1714472559000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10142-024-01283-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,13]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["1283"],"URL":"https:\/\/doi.org\/10.1007\/s10142-024-01283-5","relation":{},"ISSN":["1438-793X","1438-7948"],"issn-type":[{"value":"1438-793X","type":"print"},{"value":"1438-7948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,13]]},"assertion":[{"value":"6 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}